<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04267770</url>
  </required_header>
  <id_info>
    <org_study_id>17HH4255</org_study_id>
    <nct_id>NCT04267770</nct_id>
  </id_info>
  <brief_title>Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion</brief_title>
  <acronym>FIRST1D</acronym>
  <official_title>A Study of Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults With Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomised controlled trial to contribute to the evidence base for the optimal initial
      insulin profile for adults with type 1 diabetes commencing insulin pump therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Initiation of insulin pump therapy in people with type 1 diabetes requires conversion of a
      basal insulin dose, given as once or twice daily long-acting insulin, to a continuous basal
      infusion regimen. This conversion may be based on basal insulin dose only, or total daily
      insulin dose, and may result in a flat basal insulin profile or an initial variable basal
      rate.

      Initial variable basal rates aim to replicate circadian changes in insulin requirements and
      are derived from total basal insulin in adults over 24 years old, and from weight in adults
      aged 18 to 24 years. Initial rates were developed from 63 well-controlled people with type 1
      diabetes over 14 years of age and have been assessed against a flat basal rate in a small
      randomised controlled trial with 12 participants. Mean glucose was lower in the circadian
      basal rate group with particular differences noted in the early morning when glucose rises
      were more pronounced in the flat basal rate group1.

      In 50 people with type 1 diabetes treated with insulin pump therapy, HbA1c was lower in those
      with lower basal rates at midnight, and in those with higher basal rates in the afternoon,
      suggesting a benefit of circadian patterns2. In 33 people with type 1 diabetes over 16 years
      of age basal rate distribution established at commencement of pump therapy did not alter over
      6 months3. However, a 6 month cross-over study of circadian rates and oligophasic basal rates
      showed no difference in HbA1c4.

      Following initiation on insulin pump therapy basal rates are personalised to capillary blood
      and continuous interstitial fluid glucose monitoring.

      In adults with type 1 diabetes starting insulin pump therapy there are limited data to guide
      the optimal insulin profile to rapidly achieve target glucose and minimise healthcare
      professional input.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 10, 2018</start_date>
  <completion_date type="Actual">November 9, 2018</completion_date>
  <primary_completion_date type="Actual">November 9, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Basal Insulin Rate</measure>
    <time_frame>over 24 hours after 3 rounds of basal rate testing</time_frame>
    <description>Absolute change in insulin basal rate over 24 hours after 3 rounds of basal rate testing (calculated by the sum of absolute changes for each 1 hour block compared with baseline)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>circadian insulin infusion rates</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Initial variable basal rates aim to replicate circadian changes in insulin requirements and are derived from total basal insulin in adults over 24 years old, and from weight in adults aged 18 to 24 years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>flat rates</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>flat basal rate</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin (circadian)</intervention_name>
    <description>Participant's own insulin adjusted to circadian infusion rates</description>
    <arm_group_label>circadian insulin infusion rates</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin (flat rate)</intervention_name>
    <description>Participant's own insulin set to flat basal rates</description>
    <arm_group_label>flat rates</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults ≥18 years of age

          -  Diagnosis of T1DM for &gt; 1 year

          -  On MDI with decision made to commence CSII

          -  Structured education in previous 3 years

          -  HbA1c ≤ 75mmol/mol (9%)

          -  Stimulated c-peptide &lt;200pmol/L

          -  No severe hypoglycaemia (defined as needing 3rd party assistance) in previous year

        Exclusion Criteria:

          -  Previous CSII

          -  Night or shift worker

          -  Recurrent severe hypoglycaemia

          -  Pregnant or planning pregnancy

          -  Breastfeeding

          -  Enrolled in other clinical trials

          -  Have active malignancy or under investigation for malignancy

          -  Addison's Disease

          -  Gastroparesis

          -  Autonomic neuropathy

          -  Concomitant use of GLP-1 analogues and gliptins

          -  Visual impairment

          -  Reduced manual dexterity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Imperial College Clinical Research Facility</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 11, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2020</study_first_posted>
  <results_first_submitted>March 3, 2020</results_first_submitted>
  <results_first_submitted_qc>March 19, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">March 31, 2020</results_first_posted>
  <last_update_submitted>March 19, 2020</last_update_submitted>
  <last_update_submitted_qc>March 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin, Globin Zinc</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 23, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT04267770/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Circadian Insulin Infusion Rates</title>
          <description>Initial variable basal rates aim to replicate circadian changes in insulin requirements and are derived from total basal insulin in adults over 24 years old, and from weight in adults aged 18 to 24 years.
Insulin (circadian): Participant's own insulin adjusted to circadian infusion rates</description>
        </group>
        <group group_id="P2">
          <title>Flat Rates</title>
          <description>flat basal rate
Insulin (flat rate): Participant's own insulin set to flat basal rates</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Circadian Insulin Infusion Rates</title>
          <description>Initial variable basal rates aim to replicate circadian changes in insulin requirements and are derived from total basal insulin in adults over 24 years old, and from weight in adults aged 18 to 24 years.
Insulin (circadian): Participant's own insulin adjusted to circadian infusion rates</description>
        </group>
        <group group_id="B2">
          <title>Flat Rates</title>
          <description>flat basal rate
Insulin (flat rate): Participant's own insulin set to flat basal rates</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="8"/>
                    <count group_id="B3" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.3" spread="8.6"/>
                    <measurement group_id="B2" value="33.3" spread="8.6"/>
                    <measurement group_id="B3" value="33.3" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="8"/>
                    <count group_id="B3" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Basal Insulin Rate</title>
        <description>Absolute change in insulin basal rate over 24 hours after 3 rounds of basal rate testing (calculated by the sum of absolute changes for each 1 hour block compared with baseline)</description>
        <time_frame>over 24 hours after 3 rounds of basal rate testing</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Circadian Insulin Infusion Rates</title>
            <description>Initial variable basal rates aim to replicate circadian changes in insulin requirements and are derived from total basal insulin in adults over 24 years old, and from weight in adults aged 18 to 24 years.
Insulin (circadian): Participant's own insulin adjusted to circadian infusion rates</description>
          </group>
          <group group_id="O2">
            <title>Flat Rates</title>
            <description>flat basal rate
Insulin (flat rate): Participant's own insulin set to flat basal rates</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Basal Insulin Rate</title>
          <description>Absolute change in insulin basal rate over 24 hours after 3 rounds of basal rate testing (calculated by the sum of absolute changes for each 1 hour block compared with baseline)</description>
          <units>Units of insulin</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" lower_limit="0.63" upper_limit="2.99"/>
                    <measurement group_id="O2" value="1.49" lower_limit="0.83" upper_limit="1.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>28 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Circadian Insulin Infusion Rates</title>
          <description>Initial variable basal rates aim to replicate circadian changes in insulin requirements and are derived from total basal insulin in adults over 24 years old, and from weight in adults aged 18 to 24 years.
Insulin (circadian): Participant's own insulin adjusted to circadian infusion rates</description>
        </group>
        <group group_id="E2">
          <title>Flat Rates</title>
          <description>flat basal rate
Insulin (flat rate): Participant's own insulin set to flat basal rates</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Nick Oliver</name_or_title>
      <organization>Imperial College London</organization>
      <phone>+44 20 7594 1796</phone>
      <email>nick.oliver@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

